HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/5/C1109    most recent 00105.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Mishra, R. Articles by Simonson, M. S. Search for Related Content PubMed PubMed Citation Articles by Mishra, R. Articles by Simonson, M. S.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells

¹Division of Nephrology, Department of Medicine, and ²CWRU Cancer Center, School of Medicine, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio 44106

Submitted 19 March 2003 ; accepted in final form 2 July 2003

Endothelin (ET)-1 is a vasoconstrictor and mitogen involved in vascular remodeling. Changes in gene expression that underlie control of cell growth by ET-1 remain poorly characterized. To identify pathways of growth control we used microarrays to analyze ET-1-regulated gene expression in human mesangial cells, an important ET-1 vascular target cell in vivo. Statistical assessment of differential expression (significance analysis of microarrays) revealed upregulated transcripts for growth factors [heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), fibroblast growth factor (FGF), interleukin (IL)-6] and downregulated transcripts for genes that inhibit growth (BAX, p27KIP1, DAD1). Consistent with the gene expression profile, quantitative RT-PCR and Western blotting confirmed induction of HB-EGF by ET-1. To test a functional role for HB-EGF in ET-1 signaling, we showed that exogenous HB-EGF stimulated phosphorylation of ErbB1 and growth of mesangial cells. ET-1-induced proliferation was blocked by an ErbB1 receptor-selective kinase inhibitor and by a specific ErbB1 receptor-neutralizing antibody. Proliferation in response to ET-1 was also inhibited by neutralizing antisera against human HB-EGF. Together, these results provide data for modeling ET-1 pathways for growth control and suggest a specific role for HB-EGF gene induction in mesangial cell growth in response to ET-1.

proliferation; heparin-binding epidermal growth factor-like growth factor; microarray

This article has been cited by other articles:

				R. Mishra, L. Zhu, R. L. Eckert, and M. S. Simonson TGF-beta-regulated collagen type I accumulation: role of Src-based signals Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1361 - C1369. [Abstract] [Full Text] [PDF]

				H. H. Dao, C. Bouvet, S. Moreau, P. Beaucage, R. Lariviere, M. J. Servant, J. de Champlain, and P. Moreau Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo Cardiovasc Res, July 1, 2006; 71(1): 61 - 68. [Abstract] [Full Text] [PDF]

				E. Grantcharova, H. P. Reusch, S. Grossmann, J. Eichhorst, H.-W. Krell, M. Beyermann, W. Rosenthal, and A. Oksche N-Terminal Proteolysis of the Endothelin B Receptor Abolishes Its Ability to Induce EGF Receptor Transactivation and Contractile Protein Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1288 - 1296. [Abstract] [Full Text] [PDF]

				V. Portik-Dobos, A. K. Harris, W. Song, J. Hutchinson, M. H. Johnson, J. D. Imig, D. M. Pollock, and A. Ergul Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R435 - R441. [Abstract] [Full Text] [PDF]